[Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination]. / Antivirala läkemedel vid influensa--aktuella rekommendationer. Influensaläkemedel ersätter inte vaccination men ar ett bra komplement.
Lakartidningen
; 102(49): 3802-3, 3805-6, 3808, 2005.
Article
en Sv
| MEDLINE
| ID: mdl-16408704
This article summarizes a Swedish consensus guidance document on the use of antiviral drugs in the management of influenza. Vaccination remains the cornerstone for influenza prophylaxis. Treatment with neuraminidase inhibitors is recommended for high-risk groups and individuals hospitalised with influenza. Chemoprophylaxis is targeted at high-risk groups and should be considered on a case by case basis depending on the circumstances. Unvaccinated at-risk patients or seasonal vaccine strain mismatch were identified as potential indications for antiviral prophylaxis. Oseltamivir prophylaxis can otherwise be considered for influenza in a household including an at-risk individual and in outbreaks in hospitals and nursing homes. The use of antivirals in a pandemic situation is also discussed.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Antivirales
/
Vacunas contra la Influenza
/
Gripe Humana
Tipo de estudio:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
Sv
Revista:
Lakartidningen
Año:
2005
Tipo del documento:
Article
Pais de publicación:
Suecia